2,5-dipropyldecahydroquinoline

noncompetitive blocker for nicotinic acetylcholine receptor-channels in pheochromocytoma cells & Torpedo electroplax; RN given refers to (2S-(2alpha,4abeta,5beta,8abeta)-isomer;RN for cpd without isomeric designation not avail 6/92

Also Known As:

2,5-DPDHQ; perhydro-cis-decahydroquinoline 219A

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - 2,5-dipropyldecahydroquinoline: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - 2,5-dipropyldecahydroquinoline: 1

Related Diseases

1.	Pheochromocytoma 11/01/1991 - "In pheochromocytoma PC12 cells, (+)-cis-decahydroquinoline 195A (5-methyl-2-propyl-cis-decahydroquinoline) and (+)-perhydro-cis-decahydroquinoline 219A (2,5-dipropyl-cis-decahydroquinoline) inhibit carbamylcholine-elicited sodium flux with IC50 values of 1.0 and 1.5 microM, respectively. "

Related Drugs and Biologics

1.	Sodium
2.	Carbachol (Carbastat)
3.	decahydroquinoline-5-carboxylic acid